Evaluating the impact of sexual intercourse after embryo transfer on pregnancy rates.
Sex or no Sex: That is the Question. Impact of Coital Sexual Intercourse on the Clinical Pregnancy Rate After Embryo Transfer.
This study is trying to see if having sex within 72 hours after transferring embryos can help women in heterosexual relationships get pregnant during frozen embryo transfer cycles.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Sex | Female |
| Sponsor | Fundacion Dexeus Academic / other |
| Locations | 1 site (Barcelona) |
| Trial ID | NCT04880590 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess how sexual intercourse and orgasm within 72 hours following the transfer of blastocyst-stage embryos affect clinical pregnancy rates. It focuses on women in heterosexual relationships undergoing frozen embryo transfer (FET) cycles at the Dexeus Woman Reproduction Medicine Service. The study seeks to clarify the role of sexual activity during this critical period, as many couples undergoing assisted reproductive technology (ART) may alter their sexual behavior due to concerns about influencing the outcome. Participants will be monitored to determine any correlation between sexual activity and pregnancy success.
Who should consider this trial
Good fit: Ideal candidates for this study are women in heterosexual relationships who are undergoing frozen embryo transfer.
Not a fit: Patients who are not in heterosexual relationships or those not undergoing embryo transfer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the role of sexual intercourse in enhancing pregnancy rates after embryo transfer.
How similar studies have performed: While there is limited research specifically addressing this question, similar studies in reproductive health have shown varying results regarding the impact of sexual activity on pregnancy outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with a heterosexual sexual relationship * That they carry out an embryo transfer, in a FET cycle Exclusion Criteria: * Exclusion criteria are not foreseen
Where this trial is running
Barcelona
- Hospital Universitario Quiron Dexeus — Barcelona, Spain (Recruiting)
Study contacts
- Study coordinator: Isabeth Gonzalez de Campagnolo, MD
- Email: isagon@dexeus.com
- Phone: 0034932274700
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.